← Leaderboards
David Vance Herin
University Of Texas Medical Br Galveston
$476,495
Attributed
$476,495
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249K · FY2007–09$250K$187.5K$125K$62.5K$0
'07
'08
'09
Funding mix
By agency
NIH$476,495 · 3
By mechanism
R00$249,000 · 1
K99$146,143 · 1
F31$81,352 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Medical Br Galveston
Same institution · by research overlap
- Cheryl S Watson$3,291,532
- Joel P Gallagher$1,825,399
- Mary L Thomas$776,050
- Marcy Bubar Jordan$81,352
- Z Helen Wu$2,436,547
Others in their field
Top investigators on “Drug Abuse”
- Sten H Vermund · University Of Alabama At Birmingham$115,253,143
- Lloyd D Johnston · University Of Michigan At Ann Arbor$107,231,156
- Jeffrey H Samet · Boston University Medical Campus$99,970,887
- Barbara Driver · Westat, Inc.$95,592,456
- T John Winhusen · University Of Cincinnati$74,530,561
- Willard Cates · Family Health International$66,963,584
Research focus
Drug AbuseNeuropharmacologyFunctional ImagingDoctor Of PhilosophyAgonistFacultyAbstinenceCareerCravingDextroamphetamineAwardBehaviorAdolescence (12-20)Behavioral /Social Science Research TagBehavior TestAmphetaminesAnalogClinical TrialsAdultCocaine3,4 MethylenedioxymethamphetamineConditioningCuesDopamine
Grant awards (6)
Lisdexamfetamine treatment for cocaine dependence$249,000
R00 · FY2009 · DA · contact PI
Dextroamphetamine Treatment for Comorbid Cocaine Dependence and ADHD$72,885
K99 · FY2008 · DA · contact PI
Dextroamphetamine Treatment for Comorbid Cocaine Dependence and ADHD$73,258
K99 · FY2007 · DA · contact PI
Role of 5-HT2A Receptors in MDMA induced Behavior$28,290
F31 · FY2004 · DA
Role of 5-HT2A Receptors in MDMA induced Behavior$27,453
F31 · FY2003 · DA
Role of 5-HT2A Receptors in MDMA induced Behavior$25,609
F31 · FY2002 · DA